{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:55:14Z","timestamp":1781632514528,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Giant prolactinomas are defined as pituitary adenomas (PAs)\u2009\u2265\u20094\u00a0cm with plasma prolactin level\u2009&gt;\u20091000 ng\/ml with no other co-secretory component. The reasons for development of giant prolactinomas are not clear but genetics play an important pathogenic mechanism in some PAs. In this report, we describe a middle-aged woman who incidentally was found to have an infiltrative giant prolactinoma involving the sellar, supra- and parasellar regions and occupying most of the middle fossae of the skull extending all the way to the occipital and upper cervical regions. Anteriorly, it extends to the sphenoid and parasellar sinuses, nasopharynx and nasal cavities. It was initially thought to be a nasopharyngeal cancer but biopsy from a protruding component from the right nostril showed that it was a prolactinoma. Prolactin level after several dilutions was extremely high at 277,500 ng\/ml (normal range 3.4\u201324.1 ng\/ml). Surprisingly, her pituitary function evaluation showed only mild central hypothyroidism [(FT4 11.4 pmol\/l (normal range 12\u201322) and TSH 1.9 mU\/l (normal range 0.27\u20134.2)] and hypogonadotropic hypogonadism (E2 47 pmol\/l, LH 1.9\u00a0u\/l, FSH 5.9\u00a0u\/l). Cosyntropin stimulation test was normal suggesting normal pituitary adrenal axis but insulin-induced hypoglycaemia test was not performed. In retrospect, the patient reported chronic nasal congestion and snoring, headaches on\/off and deterioration in her hearing and visual acuity over the last few years. She ascribed these symptoms to sinusitis and advancing age, respectively. Whole exome sequencing revealed a novel variant in\n                    <jats:italic>CDH23<\/jats:italic>\n                    (NM_022124.6:c.2621C\u2009&gt;\u2009A, p.Ala874Asp), a gene that has been previously reported to be associated with PAs. The patient was treated with small doses of cabergoline (0.5\u00a0mg twice weekly) and reported remarkable improvement in her symptoms. Radiological evaluation confirmed the significant response of this giant prolactinoma to cabergoline.\n                  <\/jats:p>","DOI":"10.1186\/s13023-025-04161-w","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:21:45Z","timestamp":1769689305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel germline CDH23 variant as a likely cause of an ultra-giant prolactinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Eman","family":"Albasri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balgees","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avaniyapuram Kannan","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyas","family":"Othman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Anas","family":"Dababo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Alfares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-3624","authenticated-orcid":false,"given":"Ali S.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"11","key":"4161_CR1","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1136\/jnnp.42.11.973","volume":"42","author":"L Symon","year":"1979","unstructured":"Symon L, Jakubowski J, Kendall B. Surgical treatment of giant pituitary adenomas. J Neurol Neurosurg Psychiatry. 1979;42(11):973\u201382. https:\/\/doi.org\/10.1136\/jnnp.42.11.973","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"4161_CR2","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. 2006. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab. 91(12):4769\u201375. https:\/\/doi.org\/10.1210\/jc.2006-1668","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4161_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1530\/eje-13-0503","volume":"170","author":"E Delgrange","year":"2014","unstructured":"Delgrange E, Raverot G, Bex M, Burman P, Decoudier B, Devuyst F, et al. Giant prolactinomas in women. Eur J Endocrinol. 2014;170(1):31\u201338. https:\/\/doi.org\/10.1530\/eje-13-0503.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"4161_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2010;72(3):377\u201382. https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03667.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"4161_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s11102-023-01337-0","volume":"26","author":"L Billion","year":"2023","unstructured":"Billion L, Verleye A, Block C, Heyning PV, Herdt C. 2023. Giant prolactinomas, a detailed analysis of 196 adult cases. Pituitary. 26(5):529\u201337. https:\/\/doi.org\/10.1007\/s11102-023-01337-0","journal-title":"Pituitary"},{"key":"4161_CR6","doi-asserted-by":"crossref","unstructured":"Garla VV, Gosi S, Palakodety S, Kanduri S, Kovvuru K, Gunturu M, et al. Giant prolactinomas: case series and review of the literature. 2020.","DOI":"10.14740\/jem652"},{"issue":"1","key":"4161_CR7","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s13256-024-04967-5","volume":"18","author":"T Shahbazi","year":"2024","unstructured":"Shahbazi T, Abdollahi Yeganeh S, Borzouei S, Arjipour M. 2024. Giant prolactinoma with progressive cranial settling and central herniation: a case report. J Med Case Rep. 18(1):604. https:\/\/doi.org\/10.1186\/s13256-024-04967-5","journal-title":"J Med Case Rep"},{"issue":"5","key":"4161_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/0002-9343(87)90668-1","volume":"83","author":"FY Murphy","year":"1987","unstructured":"Murphy FY, Vesely DL, Jordan RM, Flanigan S, Kohler PO. 1987. Giant invasive prolactinomas. Am J Med. 83(5):995\u20131002. https:\/\/doi.org\/10.1016\/0002-9343(87)90668-1","journal-title":"Am J Med"},{"key":"4161_CR9","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1055\/s-0035-1566124","volume":"76","author":"D Yecies","year":"2015","unstructured":"Yecies D, Ajlan A, Ratliff J, Ziskin J, Hwang P, Vogel H, et al. Giant prolactinoma presenting with neck pain and structural compromise of the occipital condyles. J Neurol Surg Rep. 2015 2;76:e297\u2013301. https:\/\/doi.org\/10.1055\/s-0035-1566124.","journal-title":"J Neurol Surg Rep"},{"key":"4161_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.wneu.2022.09.036","volume":"169","author":"N Agrawal","year":"2023","unstructured":"Agrawal N, Gersey ZC, Abou-Al-Shaar H, Gardner PA, Mantica M, Agnihotri S, et al. Major genetic motifs in pituitary adenomas: a practical literature update. World Neurosurg. 2023;169:43\u201350.","journal-title":"World Neurosurg"},{"issue":"5","key":"4161_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ajhg.2017.03.011","volume":"100","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Peng C, Song J, Zhang Y, Chen J, Song Z, et al. Germline mutations in CDH23, encoding cadherin-related 23, are associated with both familial and sporadic pituitary adenomas. Am J Hum Genet. 2017;100(5):817\u201323. https:\/\/doi.org\/10.1016\/j.ajhg.2017.03.011.","journal-title":"Am J Hum Genet"},{"issue":"6","key":"4161_CR12","doi-asserted-by":"publisher","first-page":"bvae085","DOI":"10.1210\/jendso\/bvae085","volume":"8","author":"AS Alzahrani","year":"2024","unstructured":"Alzahrani AS, Bin Nafisah A, Alswailem M, Alghamdi B, Alsaihati B, Aljafar H, et al. Germline variants in sporadic pituitary adenomas. J Endocr Soc. 2024;8(6):bvae085. https:\/\/doi.org\/10.1210\/jendso\/bvae085.","journal-title":"J Endocr Soc"},{"issue":"8","key":"4161_CR13","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1055\/a-1143-5930","volume":"52","author":"V Vasilev","year":"2020","unstructured":"Vasilev V, Daly AF, Zacharieva S, Beckers A. Clinical and molecular update on genetic causes of pituitary adenomas. Horm Metab Res. 2020;52(8):553\u201361. https:\/\/doi.org\/10.1055\/a-1143-5930","journal-title":"Horm Metab Res"},{"issue":"3","key":"4161_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ecl.2020.05.005","volume":"49","author":"S Barry","year":"2020","unstructured":"Barry S, Korbonits M. Update on the genetics of pituitary tumors. Endocrinol Metab Clin. 2020;49(3):433\u201352. https:\/\/doi.org\/10.1016\/j.ecl.2020.05.005","journal-title":"Endocrinol Metab Clin"},{"issue":"20","key":"4161_CR15","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.1158\/1078-0432.Ccr-16-0452","volume":"22","author":"F Caimari","year":"2016","unstructured":"Caimari F, Korbonits M. Novel genetic causes of pituitary adenomas. Clin Cancer Res. 2016;22(20):5030\u201342. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-16-0452","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4161_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"},{"key":"4161_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.wneu.2023.10.025","volume":"181","author":"A Alkhaibary","year":"2024","unstructured":"Alkhaibary A, Alharbi A, Khairy S. Invasive giant prolactinoma. World Neurosurg. 2024;181:21\u201322. https:\/\/doi.org\/10.1016\/j.wneu.2023.10.025.","journal-title":"World Neurosurg"},{"issue":"2","key":"4161_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273\u201388. https:\/\/doi.org\/10.1210\/jc.2010-1692.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4161_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0272-6386(85)80181-5","volume":"6","author":"SH Hou","year":"1985","unstructured":"Hou SH, Grossman S, Molitch ME. Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis. Am J Kidney Dis. 1985;6(4):245\u201349. https:\/\/doi.org\/10.1016\/S0272-6386(85)80181-5","journal-title":"Am J Kidney Dis"},{"key":"4161_CR20","doi-asserted-by":"publisher","unstructured":"Ullah F, Zeeshan Ali M, Ahmad S, Muzammal M, Khan S, Khan J, et al. Current updates on genetic spectrum of usher syndrome. Nucleosides Nucleotides Nucleic Acids. 2024:1\u201324. https:\/\/doi.org\/10.1080\/15257770.2024.2344194.","DOI":"10.1080\/15257770.2024.2344194"},{"key":"4161_CR21","doi-asserted-by":"publisher","unstructured":"Liao B, Xie W, Liu R, Zhang Q, Xie T, Jia D, et al. Identification of novel CDH23 heterozygous variants causing autosomal recessive nonsyndromic hearing loss. Genes Genomics. 2025. https:\/\/doi.org\/10.1007\/s13258-024-01611-w.","DOI":"10.1007\/s13258-024-01611-w"},{"issue":"9","key":"4161_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.tcb.2014.03.007","volume":"24","author":"M Sotomayor","year":"2014","unstructured":"Sotomayor M, Gaudet R, Corey DP. Sorting out a promiscuous superfamily: towards cadherin connectomics. Trends Cell Biol. 2014;24(9):524\u201336. https:\/\/doi.org\/10.1016\/j.tcb.2014.03.007","journal-title":"Trends Cell Biol"},{"issue":"5","key":"4161_CR23","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1210\/jc.2009-2197","volume":"95","author":"SL Fougner","year":"2010","unstructured":"Fougner SL, Lekva T, Borota OC, Hald JK, Bollerslev J, Berg JP. The expression of E-cadherin in somatotroph pituitary adenomas is related to tumor size, invasiveness, and somatostatin analog response. J Clin Endocrinol Metab. 2010;95(5):2334\u201342. https:\/\/doi.org\/10.1210\/jc.2009-2197","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"4161_CR24","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/modpathol.3800965","volume":"20","author":"ZR Qian","year":"2007","unstructured":"Qian ZR, Sano T, Yoshimoto K, Asa SL, Yamada S, Mizusawa N, et al. Tumor-specific downregulation and methylation of the CDH13 (H-cadherin) and CDH1 (E-cadherin) genes correlate with aggressiveness of human pituitary adenomas. Mod Pathol. 2007;20(12):1269\u201377. https:\/\/doi.org\/10.1038\/modpathol.3800965.","journal-title":"Mod Pathol"},{"issue":"2","key":"4161_CR25","doi-asserted-by":"publisher","first-page":"12352","DOI":"10.1111\/jne.12352","volume":"28","author":"N Chauvet","year":"2016","unstructured":"Chauvet N, Roman\u00f2 N, Meunier AC, Galibert E, Fontanaud P, Mathieu MN, et al. Combining cadherin expression with molecular markers discriminates invasiveness in growth hormone and prolactin pituitary adenomas. J Neuroendocrinol. 2016;28(2):12352. https:\/\/doi.org\/10.1111\/jne.12352.","journal-title":"J Neuroendocrinol"},{"issue":"7","key":"4161_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/ng.3322","volume":"47","author":"Z Ye","year":"2015","unstructured":"Ye Z, Li Z, Wang Y, Mao Y, Shen M, Zhang Q, et al. Common variants at 10p12.31, 10q21.1 and 13q12.13 are associated with sporadic pituitary adenoma. Nat Genet. 2015;47(7):793\u201397. https:\/\/doi.org\/10.1038\/ng.3322.","journal-title":"Nat Genet"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04161-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04161-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:20:10Z","timestamp":1781630410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04161-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4161"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04161-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"26 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was approved by the Institutional Review Board of the King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia (RAC# 2130012). An informed consent was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"An informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"None of the authors have conflict of interest related to the work presented in this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"32"}}